As of 2025-09-18, the Relative Valuation of Inovio Pharmaceuticals Inc (INO) is (32.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.18 USD, the upside of Inovio Pharmaceuticals Inc based on Relative Valuation is -1611.4%.
The range of the Relative Valuation is (28.08) - (34.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 20.6x | 18.1x |
| Forward P/E multiples | 17.0x - 26.6x | 21.8x |
| Fair Price | (28.08) - (34.05) | (32.95) |
| Upside | -1387.9% - -1662.1% | -1611.4% |
| Date | P/E |
| 2025-09-16 | -1.38 |
| 2025-09-15 | -1.38 |
| 2025-09-12 | -1.44 |
| 2025-09-11 | -1.60 |
| 2025-09-10 | -1.60 |
| 2025-09-09 | -1.67 |
| 2025-09-08 | -1.74 |
| 2025-09-05 | -1.69 |
| 2025-09-04 | -1.67 |
| 2025-09-03 | -1.64 |
| 2025-09-02 | -1.56 |
| 2025-08-29 | -1.44 |
| 2025-08-28 | -1.49 |
| 2025-08-27 | -1.49 |
| 2025-08-26 | -1.24 |
| 2025-08-25 | -1.18 |
| 2025-08-22 | -1.19 |
| 2025-08-21 | -1.16 |
| 2025-08-20 | -1.12 |
| 2025-08-19 | -1.17 |
| 2025-08-18 | -1.15 |
| 2025-08-15 | -1.13 |
| 2025-08-14 | -0.98 |
| 2025-08-13 | -1.03 |
| 2025-08-12 | -0.90 |
| 2025-08-11 | -0.87 |
| 2025-08-08 | -0.85 |
| 2025-08-07 | -0.87 |
| 2025-08-06 | -0.88 |
| 2025-08-05 | -0.90 |
| 2025-08-04 | -0.89 |
| 2025-08-01 | -0.87 |
| 2025-07-31 | -0.86 |
| 2025-07-30 | -0.87 |
| 2025-07-29 | -0.87 |
| 2025-07-28 | -0.90 |
| 2025-07-25 | -0.89 |
| 2025-07-24 | -0.91 |
| 2025-07-23 | -0.94 |
| 2025-07-22 | -0.88 |
| 2025-07-21 | -0.86 |
| 2025-07-18 | -0.84 |
| 2025-07-17 | -0.83 |
| 2025-07-16 | -0.81 |
| 2025-07-15 | -0.79 |
| 2025-07-14 | -0.82 |
| 2025-07-11 | -0.82 |
| 2025-07-10 | -0.84 |
| 2025-07-09 | -0.88 |
| 2025-07-08 | -0.81 |